Overview
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersVancouver, Canada1
- Incorporated inBritish Columbia, Canada2
- Business addressSuite 2700,, 1133 Melville Street, Vancouver, A1 V6E 4E52
- Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2
See how the biggest companies compare on our leaderboards
On December 14, 2022, the Board of Directors of the Company approved a change to its fiscal year from February 28 to December 31. The Company's fiscal year now begins on January 1 and ends on December 31 of each year, starting on January 1, 2023.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue64¢40.1M CAD
- Other costs32¢19.8M CAD
- Interest4¢2.6M CAD
- Income tax0¢57.1K CAD
Out of 62.6M CAD in revenue.4 The company lost money this year.
Financial statements
| Fiscal year | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 149.9K CAD5 | 18.3M CAD5 | 62.6M CAD4 | |
| Cost of revenue | 0 CAD5 | 12.4M CAD5 | 40.1M CAD4 | |
| Gross profit | -33.5K CAD5 | 6.0M CAD5 | 22.5M CAD4 | |
| Operating expenses | 5.7M CAD5 | 28.1M CAD4 | ||
| Operating income | -1.0M CAD5 | 233.8K CAD5 | -5.5M CAD4 | |
| Interest | 0 CAD5 | 388.1K CAD5 | 2.6M CAD4 | |
| Income before tax | -4.5M CAD5 | -15.5M CAD4 | ||
| Income tax | 0 CAD5 | -101.6K CAD5 | 57.1K CAD4 | |
| Net income | -2.7M CAD5 | -4.4M CAD5 | -15.6M CAD4 | |
| Earnings per share | -0 CAD/shares4 | |||
| Earnings per share (diluted) | -0 CAD/shares5 | -0 CAD/shares5 | -0 CAD/shares4 | |
| Shares (weighted, basic) | 43.6M shares5 | 73.5M shares4 | ||
| Shares (weighted, diluted) | 43.6M shares5 | 73.5M shares4 |
| Fiscal year | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Cash | 8.3M CAD5 | 7.1M CAD5 | 1.9M CAD4 | 918.7K CAD4 |
| Receivables | 6.4M CAD4 | 7.8M CAD4 | ||
| Inventory | 8.1M CAD4 | 10.2M CAD4 | ||
| Current assets | 13.1M CAD5 | 16.6M CAD4 | 21.0M CAD4 | |
| Property, plant and equipment | 3.4M CAD4 | 3.4M CAD4 | ||
| Goodwill | 13.7M CAD4 | 6.4M CAD4 | ||
| Intangible assets | 9.4M CAD4 | 7.0M CAD4 | ||
| Total assets | 13.1M CAD5 | 52.1M CAD4 | 48.3M CAD4 | |
| Accounts payable | 5.3M CAD4 | 6.9M CAD4 | ||
| Short-term debt | 195.5K CAD4 | 10.4M CAD4 | ||
| Current liabilities | 6.5M CAD5 | 30.2M CAD4 | 37.6M CAD4 | |
| Long-term debt | 0 CAD5 | 574.5K CAD4 | 257.2K CAD4 | |
| Total liabilities | 6.5M CAD5 | 36.7M CAD4 | 44.3M CAD4 | |
| Retained earnings | -49.3M CAD4 | -64.9M CAD4 | ||
| Shareholders’ equity | 9.5M CAD5 | 6.6M CAD5 | 15.3M CAD4 | 4.0M CAD4 |
| Shares outstanding | 53.7M shares4 | 57.0M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Cash from operations | -975.2K CAD5 | -3.7M CAD5 | -918.9K CAD4 | |
| Depreciation and amortization | 841.8K CAD5 | 1.0M CAD4 | ||
| Stock-based compensation | 1.2M CAD5 | 1.3M CAD4 | ||
| Capital spending | 0 CAD5 | 55.3K CAD5 | 203.3K CAD4 | |
| Free cash flow | -975.2K CAD | -3.8M CAD | -1.1M CAD | |
| Cash from investing | -4.6M CAD5 | -1.5M CAD4 | ||
| Cash from financing | 3.9M CAD5 | 824.5K CAD4 |
Compare EVOME MEDICAL TECHNOLOGIES INC. with another company
What it owns
What EVOME MEDICAL TECHNOLOGIES INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | 5.0M CAD4 Dec 31, 2023 | 3.9M CAD9 Dec 31, 2022 | +29.5% |
| Accumulated depreciation | 1.6M CAD4 Dec 31, 2023 | 477.6K CAD9 Dec 31, 2022 | +235.6% |
| Property and equipment, net | 3.4M CAD4 Dec 31, 2023 | 3.4M CAD4 Dec 31, 2022 | +0.5% |
| Operating-lease assets (leased space) | 9.6M CAD4 Dec 31, 2023 | 7.8M CAD4 Dec 31, 2022 | +23.9% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | 918.7K CAD4 Dec 31, 2023 | 1.9M CAD4 Dec 31, 2022 | −52.4% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | 6.4M CAD4 Dec 31, 2023 | 13.7M CAD4 Dec 31, 2022 | −53.3% |
| Intangible assets, net (excluding goodwill) | 7.0M CAD4 Dec 31, 2023 | 9.4M CAD4 Dec 31, 2022 | −25.1% |
| Finite-lived intangibles, gross | 12.7M CAD4 Dec 31, 2023 | 10.8M CAD4 Dec 31, 2022 | +17.7% |
| Accumulated amortization | 5.6M CAD4 Dec 31, 2023 | 1.4M CAD4 Dec 31, 2022 | +307.5% |
| Finite-lived intangibles, net | 7.0M CAD4 Dec 31, 2023 | 9.4M CAD4 Dec 31, 2022 | −25.1% |
Inventory
Leadership
Who has led EVOME MEDICAL TECHNOLOGIES INC., and when. Pick a name to see everywhere that person has worked.
Board members and other officers (4)
- Board memberJane E. Kiernan May 28, 2021 to May 28, 202110
- Board memberKenneth Blair Kashkin May 28, 2021 to May 28, 202111
- Board memberKyle Lowell Wilks May 28, 2021 to Jul 9, 202112
- Board memberLeslie H. Cross May 28, 2021 to Jun 11, 202113
Former names
Timeline
- Apr 15, 20248-K Other events14
- Apr 4, 20248-K Entered a material agreement; Completed an acquisition or sale; Regulation FD disclosure15
- Apr 1, 20248-K Results of operations; Regulation FD disclosure16
- Feb 23, 20248-K Executive or director change; Regulation FD disclosure17
- Feb 9, 20248-K Other events18
- Feb 2, 20248-K Executive or director change; Regulation FD disclosure19
- Jan 23, 20248-K Executive or director change; Bylaws or fiscal year changed; Regulation FD disclosure20
- Jan 16, 20248-K Executive or director change; Other events21
- Dec 28, 20238-K Other events22
- Nov 20, 20238-K Other events23
- Nov 20, 20238-K Results of operations24
- Oct 31, 20238-K Other events25
Calendar
When it reported results
- Apr 1, 2024Reported quarterly or annual results16
- Nov 20, 2023Reported quarterly or annual results24
- Apr 7, 2023Reported quarterly or annual results26
- Jan 17, 2023Reported quarterly or annual results27
- Oct 17, 2022Reported quarterly or annual results28
- Jul 14, 2022Reported quarterly or annual results29
- Apr 5, 2022Reported quarterly or annual results30
- Jan 13, 2022Reported quarterly or annual results31
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
80 filings to the SEC since October 2021: 3 annual reports, 8 quarterly reports, 49 major events, 20 other. The latest 20:
- Dec 5, 20246-K EDGAR
- Nov 13, 20246-K EDGAR
- Aug 15, 20246-K EDGAR
- Aug 13, 20246-K EDGAR
- Jul 3, 20246-K EDGAR
- Jun 17, 20246-K EDGAR
- Jun 3, 20246-K EDGAR
- Jun 3, 20246-K EDGAR
- May 31, 20246-K EDGAR
- Apr 23, 20246-K EDGAR
- Apr 16, 202410-K EDGAR
- Apr 15, 20248-K EDGAR
- Apr 4, 20248-K EDGAR
- Apr 1, 20248-K EDGAR
- Apr 1, 2024NT 10-K EDGAR
- Feb 23, 20248-K EDGAR
- Feb 9, 20248-K EDGAR
- Feb 2, 20248-K EDGAR
- Jan 23, 20248-K EDGAR
- Jan 16, 20248-K EDGAR
The 80 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How EVOME MEDICAL TECHNOLOGIES INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAREVOME MEDICAL TECHNOLOGIES INC.1
- CIK0001617765
- Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
- Incorporated inBritish Columbia, Canada1
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business addressSuite 2700,, 1133 Melville Street, Vancouver, A1 V6E 4E51
- Phone800-760-68261
- Shares outstanding57,833,591 as of Apr 9, 20244
- Public float$11.3M as of Dec 31, 20234
- On EDGAR sinceAug 27, 20141
- Filings114 in all: 8-K (49), 6-K (10), 10-Q (9), 3 (7), UPLOAD (6), 4 (4), D (4), CORRESP (3)1
All 21 form types
EFFECT (3), S-1/A (3), 10-K (2), DRS/A (2), DRSLTR (2), NT 10-K (2), S-1 (2), 10-KT (1), 10-Q/A (1), D/A (1), DRS (1), POS AM (1), S-8 (1)
- Latest filingsAnnual report (10-K) Apr 16, 2024
Quarterly report (10-Q) Nov 14, 2023
Latest 8-K (8-K) Apr 15, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARJane E. Kiernan, Board member
- 11SEC EDGARKenneth Blair Kashkin, Board member
- 12SEC EDGARKyle Lowell Wilks, Board member
- 13SEC EDGARLeslie H. Cross, Board member
- 14SEC EDGAROther events
- 15
- 16
- 17
- 18SEC EDGAROther events
- 19
- 20
- 21
- 22SEC EDGAROther events
- 23SEC EDGAROther events
- 24SEC EDGARResults of operations
- 25SEC EDGAROther events
- 26
- 27
- 28
- 29
- 30
- 31